logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Idiopathic Pulmonary Fibrosis

    FiltersReset Filters
    7 results

    • ofev

      (nintedanib)
      Boehringer Ingelheim Pharmaceuticals, Inc.
      Usage: OFEV is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases with a progressive phenotype, and to slow pulmonary function decline in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

    • pirfenidone

      (Pirfenidone)
      EXELAN PHARMACEUTICALS INC.
      Usage: Pirfenidone is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).

    • pirfenidone

      (PIRFENIDONE)
      MSN LABORATORIES PRIVATE LIMITED
      Usage: Pirfenidone is indicated for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by scarring of lung tissue.

    • pirfenidone

      (Pirfenidone)
      ANI Pharmaceuticals Inc
      Usage: Pirfenidone is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).

    • pirfenidone

      (Pirfenidone)
      Amneal Pharmaceuticals NY LLC
      Usage: Pirfenidone tablets are indicated for the treatment of idiopathic pulmonary fibrosis (IPF).

    • pirfenidone

      (Pirfenidone)
      Alembic Pharmaceuticals Inc.
      Usage: Pirfenidone tablets are indicated for treating idiopathic pulmonary fibrosis (IPF).

    • rayos

      (prednisone)
      Horizon Therapeutics USA, Inc.
      Usage: RAYOS is indicated for severe allergic conditions, various dermatologic and endocrine diseases, gastrointestinal disorders (like Crohn's and ulcerative colitis), hematologic issues, neoplasms, nervous system conditions (such as multiple sclerosis), certain ophthalmic diseases, organ transplant rejection, pulmonary disorders, renal conditions, rheumatologic ailments, and specific infectious diseases.